Ordan Lehmann
1Patents
0h-index
1Co-inventors
16Inventor score
Filing activity: Feb 18, 2019 → Feb 18, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11001618B2 | Overexpression of FOXC1 to treat corneal vascularization | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.